Bath PUVA Revisited: Advantages,Disadvantages and Techniques

Feldman S.R. , Koo J.Y. , Menter A. , Bagel J. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005; 53: 101–7.

Weinstein G.D. , Gottlieb A.B. , Therapy of Moderate-to-Severe Psoriasis. 2nd Edition, Markel Dekker INC. New York. 2003.

Karrer Sigrid , Eholzer Christian , Ackermann Günther , Landthaler Michael , Rolf-Markus Szeimies Phototherapy of Psoriasis: Comparative Experience of Different Phototherapeutic Approaches Dermatology 2001; 202: 108–115.

Lowe N.J. , Weingarten D. , Bourget T. , Moy L.S. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol. 1986 May; 14(5 Pt 1): 754–60.

Schempp C.M. , Muller H. , Czech W. , Schopf E. , Simon J.C. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol. 1997 May; 36(5 Pt 1): 733–7.

Halpern S.M. , Anstey A.V. , Dawe R.S. , Diffey B.L. , Farr P.M. , Ferguson J. , Hawk J.L. , Ibbotson S. , McGregor J.M. , Murphy G.M. , Thomas S.E. , Rhodes L.E. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol. 2000 Jan; 142(1): 22–31.

Stern R.S. , Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 1994; 73: 2759–64.

Griffiths C.E. , Clark C.M. , Chalmers R.J. , Li Wan P.A. , Williams H.C. A systematic review of treatments for severe psoriasis. Health Techn Assess 2000; 4: 1–125.

Gach J.E. , Madrigal A.M. , Hutton J.L. , Charles-Holmes R. Retrospective analysis of the occurrence of internal malignancy in patients treated with PUVA between 1986 and 1999 in South Warwickshire. Clin Exp Dermatol. 2004 Mar; 29(2): 154–5.

Pham C.T. , Koo J.Y. Plasma levels of 8-methoxypsoralen after topical paint PUVA. J Am Acad Dermatol. 1993 Mar; 28(3): 460–6.

Hannuksela-Svahn A. , Sigurgeirsson B. , Pukkala E. , Lindelof B. , Berne B. , Hannuksela M. , Poikolainen K. , Karvonen J. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol. 1999 Sep; 141(3): 497–501.

Hannuksela-Svahn A. , Pukkala E. , Koulu L. , Jansen C.T. , Karvonen J. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. J Am Acad Dermatol. 1999 May; 40(5 Pt 1): 694–6.

Snellman E. , Rantanen T. , Sundell J. Cumulative UV radiation dose and outcome in clinical practice: effectiveness of trioxsalen bath PUVA with minimal UVA exposure. Photodermatol Photoimmunol Photomed. 2000 Oct; 16(5): 207–10.

Lindelof B. , Sigurgeirsson B. , Tegner E. , Larko O. , Johannesson A. , Berne B. , Ljunggren B. , Andersson T. , Molin L. , Nylander-Lundqvist E. , Emtestam L. Br J Dermatol. 1999 Jul; 141(1): 108–12. PUVA and cancer risk: the Swedish follow-up study

Stern R.S. , Nichols K.T. , Vakeva L.H. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study N Engl J Med. 1997 Apr 10; 336(15): 1041–5.

Feldman S.R. , Garton R. , Averett W. , Balkrishnan R. , Vallee J. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost. Expert Opin Pharmacother. 2003; 4: 1525–33.